Prime Medicine, Inc. Common Stock (PRME) — Capital Reinvestment Ratio

Latest as of December 2024: 0.11x

Prime Medicine, Inc. Common Stock (PRME) has a Capital Reinvestment Ratio of 0.11x as of December 2024, meaning it reinvests 0% of its operating cash flow ($16.25 Million) in capital expenditures ($1.79 Million). See Prime Medicine, Inc. Common Stock free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.11x
Capex / Operating Cash Flow

Operating Cash Flow

$16.25 Million
USD

Capital Expenditures

$1.79 Million
USD

Data as of

Dec 2024
Most recent filing

Annual Capital Reinvestment Ratio for Prime Medicine, Inc. Common Stock (None–None)

Year-by-year Capital Reinvestment Ratio for Prime Medicine, Inc. Common Stock from None to None. For live market cap and broader valuation context, see Prime Medicine, Inc. Common Stock market cap and net worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow